IANNETTA, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 5.181
AS - Asia 3.916
EU - Europa 2.351
SA - Sud America 640
AF - Africa 89
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 7
Totale 12.209
Nazione #
US - Stati Uniti d'America 5.059
SG - Singapore 1.977
IT - Italia 698
CN - Cina 596
BR - Brasile 527
HK - Hong Kong 486
RU - Federazione Russa 436
VN - Vietnam 345
IE - Irlanda 289
DE - Germania 189
FR - Francia 143
JP - Giappone 127
GB - Regno Unito 123
SE - Svezia 99
FI - Finlandia 85
IN - India 78
NL - Olanda 77
CA - Canada 69
AT - Austria 49
ID - Indonesia 49
AR - Argentina 44
TR - Turchia 43
PL - Polonia 41
BD - Bangladesh 40
MX - Messico 35
IQ - Iraq 33
ES - Italia 32
ZA - Sudafrica 28
KR - Corea 26
AU - Australia 24
PK - Pakistan 19
EC - Ecuador 18
CO - Colombia 15
IR - Iran 14
PH - Filippine 12
BE - Belgio 10
CL - Cile 10
CZ - Repubblica Ceca 10
EG - Egitto 10
KE - Kenya 10
LT - Lituania 10
MA - Marocco 10
UA - Ucraina 10
VE - Venezuela 10
CH - Svizzera 9
PY - Paraguay 9
JO - Giordania 8
TN - Tunisia 8
IL - Israele 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
GR - Grecia 6
MY - Malesia 6
UZ - Uzbekistan 6
KG - Kirghizistan 5
PE - Perù 5
AZ - Azerbaigian 4
DK - Danimarca 4
EU - Europa 4
GH - Ghana 4
HU - Ungheria 4
JM - Giamaica 4
NG - Nigeria 4
NP - Nepal 4
BB - Barbados 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
HR - Croazia 3
LV - Lettonia 3
MK - Macedonia 3
RO - Romania 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TW - Taiwan 3
BG - Bulgaria 2
CR - Costa Rica 2
ET - Etiopia 2
HN - Honduras 2
OM - Oman 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
GA - Gabon 1
GT - Guatemala 1
KH - Cambogia 1
KZ - Kazakistan 1
LC - Santa Lucia 1
Totale 12.199
Città #
Singapore 1.031
San Jose 535
Hong Kong 478
Ashburn 385
Fairfield 357
Wilmington 292
Chandler 261
Beijing 260
Rome 240
Houston 221
Dublin 218
Council Bluffs 157
New York 151
Medford 150
Santa Clara 147
Los Angeles 139
The Dalles 138
Woodbridge 136
Tokyo 126
Ho Chi Minh City 124
Cambridge 118
Seattle 117
Ann Arbor 80
Buffalo 77
Lawrence 69
Hanoi 68
Lauterbourg 65
Moscow 62
Helsinki 55
Nuremberg 54
Milan 51
Munich 47
San Diego 46
Chicago 43
Dallas 42
Frankfurt am Main 42
São Paulo 40
Orem 33
North Bergen 32
London 30
Toronto 30
Jakarta 29
Lappeenranta 26
Seoul 25
Warsaw 22
Chennai 21
Curitiba 21
Menlo Park 21
Rio de Janeiro 21
Da Nang 20
Brooklyn 19
Montreal 19
Amsterdam 17
Denver 17
Engelhard 17
Stockholm 17
Atlanta 15
Naples 15
Vienna 15
Ankara 14
Boardman 14
Colorado Springs 14
Haiphong 13
Johannesburg 13
Mexico City 13
Phoenix 13
San Francisco 13
Falls Church 12
Istanbul 12
Palo Alto 12
Salt Lake City 12
Adelaide 11
Kilburn 11
Manchester 11
Tampa 11
Belo Horizonte 10
Brussels 10
Elk Grove Village 10
Guangzhou 10
Miami 10
Paris 10
Boston 9
Redondo Beach 9
Sydney 9
Umuarama 9
Biên Hòa 8
Bologna 8
Chandigarh 8
Mumbai 8
Quito 8
Wuhan 8
Amman 7
Brno 7
City of London 7
Creede 7
Dearborn 7
Madrid 7
Manila 7
Nairobi 7
Poplar 7
Totale 7.510
Nome #
Low testosterone levels and high estradiol to testosterone ratio are associated with hyperinflammatory state and mortality in hospitalized men with COVID-19 384
Reactivation of Hepatitis B Virus With Immune-Escape Mutations After Ocrelizumab Treatment for Multiple Sclerosis 276
Depressive and anxiety symptoms in patients with SARS-CoV2 infection 206
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection 179
Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients 174
Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab 155
Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study 153
Cryptic HBV replicative activity is frequently revealed in anti-HBC-positive/hbsag-negative patients with HIV infection by highly sensitive molecular assays, and can be predicted by integrating classical and novel serological HBV markers 152
Chikungunya Outbreak in the Republic of the Congo, 2019—Epidemiological, Virological and Entomological Findings of a South-North Multidisciplinary Taskforce Investigation 152
Long-term SARS-CoV-2 infection associated with viral dissemination in different body fluids Including bile in two patients with acute cholecystitis 151
Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severity 147
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing 141
T-cell responses to SARS-CoV-2 in Multiple Sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-Spike antibody titers 137
B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications 132
Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in {SARS}-{CoV}-2 infected patients: a single center study 130
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21 124
Longitudinal Evaluation of the QuantiFERON-TB Gold Plus Assay in Hospitalized COVID-19 Patients with a First Indeterminate Result: Resolution of Inflammation and Restoration of T-Lymphocyte Counts and Interferon-Gamma Production 123
Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients 123
Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients 118
Early and Polyantigenic CD4 T Cell Responses Correlate with Mild Disease in Acute COVID-19 Donors 116
Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon 112
Human Arboviral Infections in Italy: Past, Current, and Future Challenges 111
Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae 111
In patients with severe COVID-19, the profound decrease in the peripheral Bblood T-cell subsets is correlated with an increase of QuantiFERON-TB Gold Plus indeterminate rates and reflecting a reduced interferon-gamma production 111
Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatment 109
Blood myeloid dendritic cells and slanDC in antiretroviral therapy-Suppressed HIV-infected patients 108
Persistence of circulating CD169+monocytes and HLA-DR downregulation underline the immune response impairment in PASC individuals: the potential contribution of different COVID-19 pandemic waves 107
Persistent detection of dengue virus RNA in vaginal secretion of a woman returning from Sri Lanka to Italy, April 2017 106
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 106
Archetype and rearranged non-coding control regions in urothelial bladder carcinoma of immunocompetent individuals 103
Validation of the T-Lymphocyte Subset Index (TLSI) as a Score to Predict Mortality in Unvaccinated Hospitalized COVID-19 Patients 102
Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters 102
High CD169 monocyte/lymphocyte ratio reflects immunophenotype disruption and oxygen need in COVID-19 patients 102
Conventional Dendritic Cells and Slan+ Monocytes During HIV-2 Infection 101
Circulation of sars-cov-2 variants in central Italy: spike variability characterization by deep-sequencing. 100
Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study) 99
Role of sonication in the microbiological diagnosis of implant-associated infections: beyond the orthopedic prosthesis 99
Brain abscess caused by Actinomyces turicensis in a non-immunocompromised adult patient: a case report and systematic review of the literature 98
ZIKV infection induces an inflammatory response but fails to activate types I, II, and III IFN response in human PBMC 98
Altered antigen-presenting cells during HIV-1 infection 98
Natalizumab affects T-Cell phenotype in multiple sclerosis: Implications for JCV reactivation 97
Azithromycin Shows Anti-Zika Virus Activity in Human Glial Cells 97
High CD169 Monocyte/Lymphocyte Ratio Reflects the Immunophenotyping Disruption and Predicts Oxygen Need in COVID-19 Patients 97
Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection 96
P-375. Long-Term Suppressive Antimicrobial Therapy in Prosthetic Vascular Graft Infection: a Five-Year Retrospective Evaluation 95
T Lymphocyte Subset Counts and Interferon-Gamma Production in Adults and Children with COVID-19: A Narrative Review 95
Cell-associated {HIV} cross-presentation by plasmacytoid dendritic cells is potentiated by noncognate {CD}8$mathplus$ T cell preactivation 94
In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-γ T cell response 93
Histoplasmosis in patients living with HIV in Europe: review of literature 93
Severe Plasmodium ovale malaria complicated by acute respiratory distress syndrome in a young Caucasian man 91
Hiv-2 infection in a migrant from gambia: The history of the disease combined with phylogenetic analysis revealed the real source of infection 91
JC Virus-DNA Detection Is Associated with CD8 Effector Accumulation in Peripheral Blood of Patients with Multiple Sclerosis under Natalizumab Treatment, Independently from JC Virus Serostatus 91
Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication 90
Low testosterone levels and high estradiol to testosterone ratio are associated with hyperinflammatory state and mortality in hospitalized men with COVID-19 (vol 25, pg 5889, 2021) 89
Remdesivir Influence on SARS-CoV-2 RNA Viral Load Kinetics in Nasopharyngeal Swab Specimens of COVID-19 Hospitalized Patients: A Real-Life Experience 89
Unexpected human cases of cutaneous anthrax in Latium region, Italy, August 2017: integrated human-animal investigation of epidemiological, clinical, microbiological and ecological factors 89
Role of HBcAb Positivity in Increase of HIV-RNA Detectability after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Months 48 Results of a Multicenter Italian Cohort 88
HUMAN ENDOGENOUS RETROVIRUSES EXPRESSION CORRELATES WITH HIV RESERVOIR, LYMPHOCYTES ACTIVATION AND LOW CD4 COUNT IN VIROLOGICALLY SUPPRESSED PATIENTS 87
An in-depth characterization of VOCs circulation by using NGS analysis of the Spike protein. 87
Case report: Delayed diagnosis of congenital malaria by plasmodium vivax in a newborn of an Eritrean woman with varicella infection 87
Imported severe malaria and risk factors for intensive care: A single-centre retrospective analysis 87
HIV DNA viral reservoirs in blood and gut-associated lymphoid tissues (GALT): Implications of switch from triple antiretroviral therapy (ART) to 2-drug dolutegravir/lamivudine regimens 86
Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical hiv-associated atherosclerosis 86
HDV replicative activity parallels the production of the three HBsAg forms (Large, Middle and Small HBsAg) and its pathogenetic impact is exacerbated by concomitant HBV replication 85
Viral Hemorrhagic Fevers Other than Ebola and Lassa 85
Severe bloodstream infection due to KPC-producer e coli in a renal transplant recipient treated with the double-carbapenem regimen and analysis of in vitro synergy testing a case report 85
HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA After Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort 85
Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection 85
Admission eGFR predicts in-hospital mortality independently of admission glycemia and C-peptide in patients with type 2 diabetes mellitus and COVID-19 84
Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections 84
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April–December 2021 in Italy 83
In vivo release of alpha-defensins in plasma, neutrophils and CD8 T-lymphocytes of patients with HIV infection 83
HIV-associated progressive multifocal leukoencephalopathy: Longitudinal study of JC virus non-coding control region rearrangements and host immunity 82
Impact of IFN-Free and IFN-Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan-DC, and Activated T Lymphocyte Dynamics during HCV Infection. 82
HIV-associated progressive multifocal leukoencephalopathy: Current perspectives 81
The Impact of Viral and Bacterial Co-Infections and Home Antibiotic Treatment in SARS-CoV-2 Hospitalized Patients at the Policlinico Tor Vergata Hospital, Rome, Italy 79
Early Atherosclerosis in HIV Infected Subjects on Suppressive Antiretroviral Treatment: Role of Osteoprotegerin 79
JCPyV NCCR analysis in PML patients with different risk factors: exploring common rearrangements as essential changes for neuropathogenesis 79
The Omicron Variant Is Associated with a Reduced Risk of the Post COVID-19 Condition and Its Main Phenotypes Compared to the Wild-Type Virus: Results from the EuCARE-POSTCOVID-19 Study 78
Resistance to Ceftazidime/Avibactam in Klebsiella pneumoniae KPC-Producing Isolates: A Real-Life Observational Study 78
The evolving landscape of COVID-19: Factors associated with in-hospital COVID-19 related mortality during the 2023-2024 phase of JN.1 subvariant dominance 78
Humoral Response after Two Doses of BNT162b2 mRNA Vaccine Has a Role in Predicting Response after Three Doses That Is Related to Plasma HIV Viremia and Nadir CD4+ Cell Count in HIV-Positive Patients 77
NMR-based metabolomic approach to study urine samples of chronic inflammatory rheumatic disease patients 77
Higher levels of osteoprotegerin and immune activation/immunosenescence markers are correlated with concomitant bone and endovascular damage in HIV-suppressed patients 76
Pacemaker lead endocarditis due to multidrug-resistant Corynebacterium striatum detected with sonication of the device 76
Evaluation of S-RBD and high specificity ACE-2-binding antibodies on SARS-CoV-2 patients after six months from infection 76
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. 76
Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses 75
Primary retroperitoneal abscesses due to Rhodococcus equi in a patient with severe nephrotic syndrome: successful antibiotic treatment with linezolid and tigecycline 74
Prolonged detection of dengue virus RNA in the semen of a man returning from Thailand to Italy, january 2018 74
null 74
Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplant Recipients: A Retrospective Italian Cohort Study in Tor Vergata University Hospital, Rome 73
Hepatitis B-related hepatic flare during immune reconstitution syndrome after antiretroviral treatment initiation in an HBV surface antigen-positive patient with HIV: viroimmunological and histological characterization 73
Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia 73
Chronic HDV coinfection (CHD) is characterized by a different HBsAg isoforms composition respect to HBV mono-infection with higher middle- and large-HBs levels paralleling the replicative and cytolytic activity of HDV. 68
Which is the best PML risk stratification strategy in natalizumab-treated patients affected by multiple sclerosis? 68
The intrahepatic activity of Hepatitis Delta virus is sustained by an abundant production of HBs transcripts, mainly derived from integrated HBV-DNA, and is not strictly related to the extent of HBV reservoir 68
Neuro-Axonal Damage and Alteration of Blood–Brain Barrier Integrity in COVID-19 Patients 67
A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. 67
A Serum Multi-Parametric Analysis Identifies an Early Innate Immune Signature Associated to Increased Vaccine-Specific Antibody Production and Seroconversion in Simultaneous COVID-19 mRNA and Cell-Based Quadrivalent Influenza Vaccination 67
Totale 10.305
Categoria #
all - tutte 63.279
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.279


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202141 0 0 0 0 0 0 0 0 0 0 24 17
2021/2022974 90 120 55 128 8 77 58 70 63 58 33 214
2022/2023845 84 44 51 62 75 214 92 64 65 12 42 40
2023/2024643 64 22 58 88 43 102 29 44 14 71 23 85
2024/20253.253 72 571 396 193 55 183 334 167 308 431 251 292
2025/20265.673 650 257 607 526 520 261 792 723 806 516 15 0
Totale 12.774